US FDA inspects Samsung Biologics facilities in South Korea
Seoul, May 21 (IANS) The US Food and Drug Administration (FDA) is currently conducting an on-site inspection of Samsung Biologics’ production facilities in South Korea, industry sources said on Wednesday.… Continue reading US FDA inspects Samsung Biologics facilities in South Korea







